Skip to main content

ADVERTISEMENT

HER2− Breast Cancer

Susan Dent, MD
Videos
10/21/2021
Susan Dent, MD, discusses the impact of cardiovascular disease (CVD) and health care utilization (HCU) on patients with HR-positive, HER2-negative, advanced breast cancer receiving endocrine therapy.
Susan Dent, MD, discusses the impact of cardiovascular disease (CVD) and health care utilization (HCU) on patients with HR-positive, HER2-negative, advanced breast cancer receiving endocrine therapy.
Susan Dent, MD, discusses the...
10/21/2021
Oncology
Saranya Chumsri, MD
Videos
09/28/2021
Saranya Chumsri, MD, Mayo Clinic, FL, highlights outcomes from a real-world study of ICIs to treat HR+, HER2-, metastatic breast cancer with a high tumor mutational burden.
Saranya Chumsri, MD, Mayo Clinic, FL, highlights outcomes from a real-world study of ICIs to treat HR+, HER2-, metastatic breast cancer with a high tumor mutational burden.
Saranya Chumsri, MD, Mayo...
09/28/2021
Oncology